Cargando…

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)

BACKGROUND: Knowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Broers, Eva R., Lodder, Paul, Spek, Viola R.M., Widdershoven, Jos W.M.G., Pedersen, Susanne S., Habibović, Mirela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850604/
https://www.ncbi.nlm.nih.gov/pubmed/30779208
http://dx.doi.org/10.1111/pace.13636
_version_ 1783469460452016128
author Broers, Eva R.
Lodder, Paul
Spek, Viola R.M.
Widdershoven, Jos W.M.G.
Pedersen, Susanne S.
Habibović, Mirela
author_facet Broers, Eva R.
Lodder, Paul
Spek, Viola R.M.
Widdershoven, Jos W.M.G.
Pedersen, Susanne S.
Habibović, Mirela
author_sort Broers, Eva R.
collection PubMed
description BACKGROUND: Knowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design. METHODS: ICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU. RESULTS: HCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. CONCLUSIONS: Depression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU.
format Online
Article
Text
id pubmed-6850604
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68506042019-11-18 Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) Broers, Eva R. Lodder, Paul Spek, Viola R.M. Widdershoven, Jos W.M.G. Pedersen, Susanne S. Habibović, Mirela Pacing Clin Electrophysiol Devices BACKGROUND: Knowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design. METHODS: ICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU. RESULTS: HCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. CONCLUSIONS: Depression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU. John Wiley and Sons Inc. 2019-03-05 2019-04 /pmc/articles/PMC6850604/ /pubmed/30779208 http://dx.doi.org/10.1111/pace.13636 Text en © 2019 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Devices
Broers, Eva R.
Lodder, Paul
Spek, Viola R.M.
Widdershoven, Jos W.M.G.
Pedersen, Susanne S.
Habibović, Mirela
Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
title Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
title_full Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
title_fullStr Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
title_full_unstemmed Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
title_short Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
title_sort healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the webcare study)
topic Devices
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850604/
https://www.ncbi.nlm.nih.gov/pubmed/30779208
http://dx.doi.org/10.1111/pace.13636
work_keys_str_mv AT broersevar healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy
AT lodderpaul healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy
AT spekviolarm healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy
AT widdershovenjoswmg healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy
AT pedersensusannes healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy
AT habibovicmirela healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy